Elana Gazal
Director Técnico/Científico/I+D en COLLPLANT BIOTECHNOLOGIES LTD. .
Fortuna: - $ al 30/04/2024
Perfil
Elana Gazal is currently the Vice President of Research & Development at CollPlant Biotechnologies Ltd.
Prior to this, she was the Head of Pharmaceutical Research at NeuroDerm Ltd.
from 2017 to 2022.
Dr. Gazal holds a doctorate degree from The Hebrew University of Jerusalem.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/03/2024 | 0 ( -.--% ) | - $ | 30/04/2024 |
Cargos activos de Elana Gazal
| Empresas | Cargo | Inicio |
|---|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Director Técnico/Científico/I+D | 01/01/2022 |
Antiguos cargos conocidos de Elana Gazal.
| Empresas | Cargo | Fin |
|---|---|---|
| NEURODERM LTD | Director Técnico/Científico/I+D | 01/11/2022 |
Formación de Elana Gazal.
| The Hebrew University of Jerusalem | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| COLLPLANT BIOTECHNOLOGIES LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
NeuroDerm Ltd.
 NeuroDerm Ltd. BiotechnologyHealth Technology NeuroDerm Ltd. operates as a clinical-stage pharmaceutical company. It engages in the development of next-generation treatments for central nervous system disorders. The company was founded by Eliahu Heldman on March 18, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Elana Gazal
